Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 4Prostatic Hyperplasia 2Neoplasms 1

Interventions

Dutasteride 2Blood Specimen Collection 2Urination 1Transurethral Resection of Prostate 1Therapeutics 1Radiotherapy 1Prostatectomy 1Prostate-Specific Antigen 1Magnetic Resonance Spectroscopy 1Adrenergic alpha-Antagonists 15-alpha Reductase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Prostatic Hyperplasia × Dutasteride × Clear all
NCT00883909 2017-07-11

ARI103094-Follow-Up Study for REDUCE Study Subjects

GlaxoSmithKline

Completed
2,795 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT01337258 2017-05-30

Economic Analyses of the REDUCE Trial

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡